Skip to main content

Advertisement

Log in

Microdose α-interferon shows clinical and antiangiogenic effect in extramedullary myeloid tumor: a case report

  • Correspondence
  • Published:
Leukemia Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1

References

  1. Byrd JC, Edenfield WJ, Shields DJ, Dawson NA . Extramedullary myeloid cell tumors in acute non lymphocytic leukemia: a clinical review. J Clin Oncology 1995; 13: 1800–1816.

    Article  CAS  Google Scholar 

  2. Menasce LP, Banerjee SS, Beckett E, Harris M . Extra-medullary myeloid tumour (granulocytic sarcoma) is often misdiagnosed: a study of 26 cases. Histopathology 1999; 34: 391–398.

    Article  CAS  Google Scholar 

  3. Pruneri G, Bertolini F, Soligo D, Carboni N, Cortelezzi A, Ferrucci PF et al. Angiogenesis in myelodysplastic syndromes. Br J Cancer 1999; 81: 1398–1401.

    Article  CAS  Google Scholar 

  4. Aguayo A, Estey E, Kantarjan H, Manshouri T, Gidel C, Keating M . Cellular vascular endothelial growth factor is a predictor of outcome in patients with acute myeloid leukemia. Blood 1999; 94: 3717–3721.

    CAS  Google Scholar 

  5. Hussong JW, Rodgers GM, Shami PJ . Evidence of increased angiogenesis in patients with acute myeloid leukemia. Blood 2000; 95: 309–313.

    CAS  Google Scholar 

  6. Marler JJ, Rubin JB, Trede NS, Connors S, Grier H, Upton J . Successful antiangiogenic therapy of giant cell angioblastoma with interferon alfa 2b: report of 2 cases. Pediatrics 2002; 109: E37.

    Article  Google Scholar 

Download references

Acknowledgements

This work was supported in part by AIL Pesaro ONLUS.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Piccaluga, P., Visani, G., Isidori, A. et al. Microdose α-interferon shows clinical and antiangiogenic effect in extramedullary myeloid tumor: a case report. Leukemia 17, 986–987 (2003). https://doi.org/10.1038/sj.leu.2402904

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2402904

  • Springer Nature Limited

This article is cited by

Navigation